DSM — Koninklijke DSM NV Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedLarge CapFalling Star

Annual income statement for Koninklijke DSM NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7,269	8,390	7,590	7,803	4,008
Cost of Revenue
Gross Profit	2,612	2,690	1,569	1,811	1,476
Selling / General / Administrative Expenses
Research And Development
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	6,558	7,708	8,002	7,693	3,679
Operating Profit	711	682	-412	110	329
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	611	594	-470	82	265
Provision for Income Taxes
Net Income After Taxes	488	470	-454	-16	176
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	1,676	1,700	2,318	-43	-762
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,670	1,694	2,312	-43	-762
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.36	2.97	-0.466	0.463	0.134
Dividends per Share